Influence of American Society of Anesthesiologists Score on Oncologic Outcomes in Patients With Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Large-Sample Study in Two Institutions

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Oct 21

PMID 34671552

Citations 4

Authors

Yichu Yuan

Yiqiu Wang

Nan Zhang

Xiawa Mao

Yiran Huang

Jiwei Huang

Na Ji

Affiliations

Soon will be listed here.

Abstract

Introduction: As a research team of urologists and an anesthetist, we sought to investigate the prognostic significance of American Society of Anesthesiologists (ASA) score in patients with upper tract urothelial cancer (UTUC) after radical nephroureterectomy (RNU). ASA physical status (ASA-PS) classification not only was found to be associated with increased comorbidities but also independently factors for predicting morbidity and mortality. Accurate risk assessment was being particularly important for patients being considered for surgery.

Methods: Records for 958 patients with UTUC who underwent RNU were reviewed. Clinicopathologic variables, including ASA-PS, were assessed at two institutions. Overall survival (OS), cancer-specific survival (CSS), intravesical recurrence-free survival (IRFS), and metastasis-free survival (MFS) were estimated using the Kaplan-Meier method and Cox regression analyses. We measured the independent predictive value of ASA-PS for mortality by multivariate regression. Association of ASA-PS and clinicopathologic variables was assessed.

Results: The group of patients with ASA = 2/3 had a shorter 5-year OS (67.6% and 49.9%), CSS (72.9% and 58.1%), and MFS (75.1% and 58.5%). The median follow-up time was 39 months. Kaplan-Meier curves showed that the group with ASA = 2/3 had significantly poorer OS, CSS, and MFS. Adjusting for multiple potential confounding factors, multivariate analyses suggested that ASA score was an independent predictor of OS, CSS, and MFS (p = 0.004, p = 0.005, p < 0.001).

Conclusion: Higher ASA scores were independently associated with lower survival rate. This capability, along with its simplicity, makes it a valuable prognostic metric. It should be seriously referenced in UTUC patients being considered for RNU.

Citing Articles

The Importance of Patient Systemic Health Status in High-Grade Chondrosarcoma Prognosis: A National Multicenter Study.

van Praag V, Molenaar D, Tendijck G, Schaap G, Jutte P, van der Geest I Cancers (Basel). 2024; 16(20).

PMID: 39456578 PMC: 11506449. DOI: 10.3390/cancers16203484.

Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?.

Marschner S, Maihofer C, Spath R, Haehl E, Reitz D, Kienlechner N Strahlenther Onkol. 2024; 200(12):1025-1037.

PMID: 39222095 PMC: 11588950. DOI: 10.1007/s00066-024-02282-y.

Ranking as a Procedure for Selecting a Replacement Variable in the Score Predicting the Survival of Patients Treated with Curative Intent for Colorectal Liver Metastases.

Plahuta I, Mencinger M, Perus I, Magdalenic T, Turk S, Brumec A Medicina (Kaunas). 2023; 59(11).

PMID: 38004052 PMC: 10673064. DOI: 10.3390/medicina59112003.

Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.

Ke H, Li C, Lee H, Tu H, Wei Y, Yeh H Cancers (Basel). 2022; 14(6).

PMID: 35326617 PMC: 8946018. DOI: 10.3390/cancers14061466.

References

Margulis V, Shariat S, Matin S, Kamat A, Zigeuner R, Kikuchi E . Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009; 115(6):1224-33. DOI: 10.1002/cncr.24135. View

Berod A, Colin P, Yates D, Ouzzane A, Audouin M, Adam E . The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study. BJU Int. 2012; 110(11 Pt C):E1035-40. DOI: 10.1111/j.1464-410X.2012.11195.x. View

Djaladat H, Bruins H, Miranda G, Cai J, Skinner E, Daneshmand S . The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU Int. 2013; 113(6):887-93. DOI: 10.1111/bju.12240. View

Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A . Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol. 2012; 62(4):662-70. DOI: 10.1016/j.eururo.2012.03.057. View

Xylinas E, Rink M, Margulis V, Clozel T, Lee R, Comploj E . Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int. 2013; 112(4):453-61. DOI: 10.1111/j.1464-410X.2012.11649.x. View

Jan H, Hu C, Yang W, Ou C . Combination of Platelet-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio as a New Promising Prognostic Factor in Upper Tract Urothelial Carcinoma With Large Tumor Sizes > 3 cm. Clin Genitourin Cancer. 2020; 18(4):e484-e500. DOI: 10.1016/j.clgc.2019.12.008. View

Chromecki T, Cha E, Fajkovic H, Margulis V, Novara G, Scherr D . The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol. 2011; 61(2):245-53. DOI: 10.1016/j.eururo.2011.09.017. View

Wolters U, Wolf T, Stutzer H, Schroder T . ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth. 1996; 77(2):217-22. DOI: 10.1093/bja/77.2.217. View

Pichler M, Dalpiaz O, Ehrlich G, Stojakovic T, Martin Hernandez J, Mannweiler S . Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma. J Urol. 2014; 191(4):920-5. DOI: 10.1016/j.juro.2013.10.073. View

10.

Gayed B, Thoreson G, Margulis V . The role of systemic chemotherapy in management of upper tract urothelial cancer. Curr Urol Rep. 2013; 14(2):94-101. DOI: 10.1007/s11934-013-0307-z. View

11.

Kolehmainen A, Pasanen A, Tuomi T, Koivisto-Korander R, Butzow R, Loukovaara M . American Society of Anesthesiologists physical status score as a predictor of long-term outcome in women with endometrial cancer. Int J Gynecol Cancer. 2019; 29(5):879-885. DOI: 10.1136/ijgc-2018-000118. View

12.

Fitz-Henry J . The ASA classification and peri-operative risk. Ann R Coll Surg Engl. 2011; 93(3):185-7. PMC: 3348554. DOI: 10.1308/rcsann.2011.93.3.185a. View

13.

Takagi K, Yagi T, Yoshida R, Shinoura S, Umeda Y, Nobuoka D . Sarcopenia and American Society of Anesthesiologists Physical Status in the Assessment of Outcomes of Hepatocellular Carcinoma Patients Undergoing Hepatectomy. Acta Med Okayama. 2016; 70(5):363-370. DOI: 10.18926/AMO/54594. View

14.

Yates D, Hupertan V, Colin P, Ouzzane A, Descazeaud A, Long J . Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer. 2012; 106(6):1083-8. PMC: 3304431. DOI: 10.1038/bjc.2012.64. View

15.

Hackett N, De Oliveira G, Jain U, Kim J . ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015; 18:184-90. DOI: 10.1016/j.ijsu.2015.04.079. View

16.

Haleblian G, Skinner E, Dickinson M, Lieskovsky G, Boyd S, SKINNER D . Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol. 1998; 160(6 Pt 1):2011-4. DOI: 10.1097/00005392-199812010-00018. View

17.

Audenet F, Yates D, Cussenot O, Roupret M . The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). Urol Oncol. 2010; 31(4):407-13. DOI: 10.1016/j.urolonc.2010.07.016. View

18.

Moch H, Cubilla A, Humphrey P, Reuter V, Ulbright T . The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016; 70(1):93-105. DOI: 10.1016/j.eururo.2016.02.029. View

19.

Schirrmacher V . From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol. 2018; 54(2):407-419. PMC: 6317661. DOI: 10.3892/ijo.2018.4661. View

20.

de Cassio Zequi S, de Campos E, Guimaraes G, Bachega Jr W, da Fonseca F, Lopes A . The use of the American Society of Anesthesiology Classification as a prognostic factor in patients with renal cell carcinoma. Urol Int. 2010; 84(1):67-72. DOI: 10.1159/000273469. View